Big announcement

1. Zijin Mining's 17.5 billion yuan mine expansion project approved

$ZIJIN MINING (02899.HK)$Its Julong Copper Mine Phase II renovation and expansion project was approved and established, with a total investment of about 17.46 billion yuan. According to the announcement, Julong Copper Mine was approved to add 200,000 tons/day to an additional production scale of 200,000 tons/day on the basis of the current 150,000 tons/day mining project, forming a total production scale of 350,000 tons/day. After production, Julong Copper will harvest more than 100 million tons of ore each year, making it the largest single copper mine selected in China and the largest single copper mine in the world that has been put into operation since the 21st century.

2. Haohai Biotechnology: Net profit returned to mother in 2023 was 416 million yuan, an increase of 130.58% over the previous year

$HAOHAI BIOTEC (06826.HK)$Announcing the 2023 Annual Results Report, the Group achieved operating revenue of RMB 2,654 billion (same unit), an increase of 24.59%; net profit attributable to shareholders of the parent company of RMB 416 million, an increase of 130.58% over the previous year; and basic earnings per share of RMB 2.44.

3. Huahong Semiconductor: Net profit due to mother in 2023 was 1,936 billion yuan, a year-on-year decrease of 35.64%

$HUA HONG SEMI (01347.HK)$Announcing the 2023 Annual Results Report, the Group achieved total operating revenue of RMB 16.232 billion (same unit), a year-on-year decrease of 3.3%; net profit attributable to owners of the parent company of RMB 1,936 billion, a year-on-year decrease of 35.64%; and basic earnings per share.

4. Times Electric: Net profit due to mother in 2023 was 3.106 billion yuan, an increase of 21.51% year-on-year

$TIMES ELECTRIC (03898.HK)$The 2023 Annual Results Report was announced. Total operating revenue was approximately RMB 21.613 billion (RMB, same below), up 19.85% year on year; net profit attributable to owners of the parent company was 3.106 billion yuan, up 21.51% year on year; net profit attributable to owners of the parent company after deducting non-recurring profit and loss was 2,558 billion yuan, up 28.03% year on year; and basic earnings per share were 2.19 yuan.

5. BYD shares: Chairman and CEO Wang Chuanfu proposed to increase the amount of A-share repurchases to 400 million yuan

$BYD COMPANY (01211.HK)$It was announced that on February 22, 2024, the company received a letter from Mr. Wang Chuanfu (proponent), the actual controller, chairman and president of the company, on proposing that BYD Co., Ltd. increase the repurchase amount of the company's A shares”. Mr. Wang Chuanfu proposed increasing the repurchase amount from RMB 200 million to RMB 400 million and using it to reduce the registered capital.

Earnings Report

$PCCW (00008.HK)$: Revenue increased 1% in 2023 to HK$36.347 billion, loss of HK$471 million year-on-year change from profit to loss

$YANCOAL AUS (03668.HK)$Net profit after tax in 2023 was $1,819 million. Proposed final interest of $0.325 per share

$REMEGEN (09995.HK)$2023 revenue of 1.08 billion yuan increased 40.26% year-on-year

$JUNSHI BIO (01877.HK)$: 2023 revenue of 1.54 billion yuan increased 5.96% year on year, net loss of 2,247 billion yuan decreased by 5.89% year on year

$SHANGHAI FUDAN (01385.HK)$Net profit of 2023 was about 725 million yuan, down 32.69% year on year

$CANSINOBIO (06185.HK)$Total revenue of 357 million yuan in 2023 decreased by 65.49% year-on-year

Operational data

$CHINA RE (01508.HK)$: The total original premium income of Dadi Financial Insurance in January was about 6.07 billion yuan

Pharmaceutical Innovation

$GENSCRIPT BIO (01548.HK)$：$Legend Biotech (LEGN.US)$Announcing positive opinions from the Human Medicines Board on the use of CARVYKTI for frontline treatment of patients with recurrent or refractory multiple myeloma

$SKB BIO-B (06990.HK)$: MSD has initiated three key phase 3 clinical trials The company has received some milestone payments relating to the triggering of this clinical trial

Repurchase cancellation

$FLAT GLASS (06865.HK)$It is proposed to buy back the company's A shares for 300 million yuan to 600 million yuan

$AIA (01299.HK)$On February 23, it cost HK$110 million to buy back 1.7 million shares

$Yum China (YUMC.US)$On February 23, it spent 20.5 million US dollars to buy back 488,000 shares and HK$20.6295 million to buy back 63,000 shares.

$KUAISHOU-W (01024.HK)$On February 23, 882,300 shares were purchased at HK$39.986 million

$HAIER SMARTHOME (06690.HK)$On February 23, it spent 32.25 million yuan to buy back 1.35 million A-shares

$COSCO SHIP HOLD (01919.HK)$2.194 million shares were purchased at HK$19.4727 million on February 23

$BANK OF E ASIA (00023.HK)$On February 23, 9331,800 shares were purchased at HK$9.231,700

$SWIRE PACIFIC A (00019.HK)$On February 23, 123,000 shares were purchased at HK$7.88 million

$KINGDEE INT'L (00268.HK)$386.95 million shares repurchased on February 23 were cancelled

edit/ruby